Anne Phillips
Direttore/Membro del Consiglio presso TREVENA, INC.
Patrimonio netto: 7 287 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Anne Phillips
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.
44
| Subsidiary | Pharmaceuticals: Major | 44 |
| Public Company | Pharmaceuticals: Major | 30 | |
| Subsidiary | Pharmaceuticals: Major | 27 | |
Royal College of Physicians & Surgeons of Canada
 Royal College of Physicians & Surgeons of Canada Other Consumer ServicesConsumer Services The Royal College of Physicians & Surgeons of Canada operates a college for medical professionals. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Andrew Padmos.
18
| Non-Profit Organization | Other Consumer Services | 18 |
| Public Company | Pharmaceuticals: Major | 17 | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.
15
| Subsidiary | Biotechnology | 15 |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA.
14
| Subsidiary | Biotechnology | 14 |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom.
13
| Holding Company | Miscellaneous Commercial Services | 13 |
| Public Company | Pharmaceuticals: Major | 12 | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
8
| Non-Profit Organization | Miscellaneous Commercial Services | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Anne Phillips tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Toronto | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Corporate Secretary Chief Executive Officer Corporate Secretary Treasurer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
| The University of Chicago Booth School of Business | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chairman | |
| Stanford University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Sales & Marketing | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
vTv Therapeutics LLC
 vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Montana Bioscience Alliance
 The Montana Bioscience Alliance Miscellaneous Commercial ServicesCommercial Services The Montana Bioscience Alliance serves as a hub for Montana’s biotechnology companies, entrepreneurs, laboratories, hospitals, clinics and universities to commercialize grow and sustain globally competitive bioscience companies. It Serve as the interface between the life sciences cluster and state government to help implement and improve the state’s life sciences cluster development strategy. The company was founded in 2004 and is headquartered in Billings, MT. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Synthekine, Inc.
 Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| Temple University (Pennsylvania) | College/University | Director/Board Member Graduate Degree | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| Dalhousie University | College/University | Graduate Degree Graduate Degree | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Stanford Law School | College/University | Graduate Degree Graduate Degree | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Chairman Founder | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member General Counsel | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services GNS Healthcare, Inc. provides analytics solutions for the healthcare industry. The firm offers solutions for electronic health records, claims, clinical and incentive programs, reward, product development solutions for biopharmaceutical, diagnostic, consumer product, and medical device companies and publications, conference abstracts, and presentations. The company was founded by Colin Hill and Iya Khalil in 2000 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
| McMaster University | College/University | Doctorate Degree Corporate Officer/Principal | |
iGan Partners
 iGan Partners Investment ManagersFinance iGan Partners (iGan Partners) is a venture capital firm founded in 2010 by Sam Ifergan. The firm is headquartered in Toronto, Canada. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
Kimia Therapeutics, Inc.
 Kimia Therapeutics, Inc. BiotechnologyHealth Technology Kimia Therapeutics, Inc. is a drug discovery company that utilizes high throughput precision chemistry, genome editing, and machine learning to identify druggable sites for human disease intervention. The private company is based in Berkeley, CA. The company is building a next-generation therapeutics discovery platform called Atlas, which combines active learning with automated synthesis and screening. Atlas is powered by a high-throughput, nano-liter scale chemistry platform that provides Kimia with instant access to billions of drug-like compounds. The CEO of the company is Stig K. Hansen. | Biotechnology | Founder Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 42 |
| Canada | 6 |
| Danimarca | 3 |
| Paesi Bassi | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Finance | 3 |
Posizioni
| Director/Board Member | 486 |
| Corporate Officer/Principal | 241 |
| Independent Dir/Board Member | 165 |
| Chairman | 109 |
| Chief Executive Officer | 84 |
Contatti più connessi
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Srini Akkaraju Akkaraju | 54 |
| Patrick Soon-Shiong | 52 |
| John Maraganore | 37 |
| Robert Perez | 31 |
| Lonnie Moulder | 31 |
| Pierre Armand Morgon | 29 |
| Gino Santini | 26 |
| Adam Koppel | 26 |
| Peter Svennilson | 25 |
| Scott Braunstein | 25 |
| Davey Scoon | 24 |
| Maxine Gowen | 23 |
| James Sulat | 23 |
| Jake Nunn | 23 |
- Borsa valori
- Insiders
- Anne Phillips
- Connessioni Società